Zoupa Ioanna

Ms. Zoupa Ioanna

Department of Biochemistry and Molecular Biology, Faculty of Biology, National and Kapodistrian University of Athens
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 March 2021 in Biomedicines
Verified
Journal Article
Open access
PDF file
Pinelopi ArtemakiPinelopi Artemaki
Pinelopi Artemaki
PLPetros Letsos
Petros Letsos
Zoupa IoannaZoupa Ioanna
Zoupa Ioanna
Katerina KatsarakiKaterina Katsaraki
Katerina Katsaraki
Paraskevi KarousiParaskevi Karousi
Paraskevi Karousi
Christos KontosChristos Kontos
Christos Kontos
Normal B-cell development is a tightly regulated complex procedure, the deregulation of which can lead to lymphomagenesis. One common group of blood cancers is the B-cell non-Hodgkin lymphomas (NHLs), which can be categorized according to the proliferation and spread rate of cancer cells into indolent and aggressive ones. The most frequent indolent B-cell NHLs are follicular lymphoma and marginal zone lymphoma. MicroRNAs (miRNAs) are small non-coding RNAs that can greatly influence protein expression. Based on the multiple interactions among miRNAs and their targets, complex networks of gene expression regulation emerge, which normally are essential for proper B-cell development. Multiple miRNAs have been associated with B-cell lymphomas, as the deregulation of these complex networks can lead to such pathological states. The aim of the present review is to summarize the existing information regarding the multifaceted role of miRNAs in indolent B-cell NHLs, affecting the main B-cell subpopulations. We attempt to provide insight into their biological function, the complex miRNA-mRNA interactions, and their biomarker utility in these malignancies. Lastly, we address the limitations that hinder the investigation of the role of miRNAs in these lymphomas and discuss ways that these problems could be overcome in the future.